Non-ischemic ventricular dysfunction in COVID-19 patients : characteristics and implications for cardiac imaging on the basis of current evidence
Coronavirus 2019 disease (COVID-19), caused by SARS-CoV-2, can lead to cardiac impairment with various types of clinical manifestations, including heart failure and cardiogenic shock. A possible expression of cardiac impairment is non-ischemic ventricular dysfunction, which can be related to different pathological conditions, such as myocarditis, stress and cytokine-related ventricular dysfunction. The diagnosis of these pathological conditions can be challenging during COVID-19; furthermore, their prevalence and prognostic significance have not been elucidated yet. The purpose of this review is to take stock of the various aspects of non-ischemic ventricular dysfunction that may occur during COVID-19 and of the diagnostic implications related to the use of cardiac imaging techniques.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Giornale italiano di cardiologia (2006) - 21(2020), 10 vom: 31. Okt., Seite 739-749 |
| Sprache: |
Italienisch |
|---|
| Weiterer Titel: |
La disfunzione ventricolare non ischemica nei pazienti con COVID-19: caratteristiche e implicazioni per l’imaging cardiaco in base alle attuali evidenze scientifiche |
|---|
| Beteiligte Personen: |
Mele, Donato [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 30.09.2020 Date Revised 18.12.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1714/3431.34196 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315391855 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315391855 | ||
| 003 | DE-627 | ||
| 005 | 20231225154821.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||ita c | ||
| 024 | 7 | |a 10.1714/3431.34196 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1051.xml |
| 035 | |a (DE-627)NLM315391855 | ||
| 035 | |a (NLM)32968306 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ita | ||
| 100 | 1 | |a Mele, Donato |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Non-ischemic ventricular dysfunction in COVID-19 patients |b characteristics and implications for cardiac imaging on the basis of current evidence |
| 246 | 3 | 3 | |a La disfunzione ventricolare non ischemica nei pazienti con COVID-19: caratteristiche e implicazioni per l’imaging cardiaco in base alle attuali evidenze scientifiche |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.09.2020 | ||
| 500 | |a Date Revised 18.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Coronavirus 2019 disease (COVID-19), caused by SARS-CoV-2, can lead to cardiac impairment with various types of clinical manifestations, including heart failure and cardiogenic shock. A possible expression of cardiac impairment is non-ischemic ventricular dysfunction, which can be related to different pathological conditions, such as myocarditis, stress and cytokine-related ventricular dysfunction. The diagnosis of these pathological conditions can be challenging during COVID-19; furthermore, their prevalence and prognostic significance have not been elucidated yet. The purpose of this review is to take stock of the various aspects of non-ischemic ventricular dysfunction that may occur during COVID-19 and of the diagnostic implications related to the use of cardiac imaging techniques | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Troponin |2 NLM | |
| 700 | 1 | |a D'Andrea, Antonello |e verfasserin |4 aut | |
| 700 | 1 | |a Campana, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Di Giannuario, Giovanna |e verfasserin |4 aut | |
| 700 | 1 | |a Flamigni, Filippo |e verfasserin |4 aut | |
| 700 | 1 | |a Gimelli, Alessia |e verfasserin |4 aut | |
| 700 | 1 | |a Khoury, Georgette |e verfasserin |4 aut | |
| 700 | 1 | |a Rizzo, Massimiliano |e verfasserin |4 aut | |
| 700 | 1 | |a Moreo, Antonella |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Giornale italiano di cardiologia (2006) |d 2006 |g 21(2020), 10 vom: 31. Okt., Seite 739-749 |w (DE-627)NLM16119561X |x 1972-6481 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2020 |g number:10 |g day:31 |g month:10 |g pages:739-749 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1714/3431.34196 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2020 |e 10 |b 31 |c 10 |h 739-749 | ||